These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34671614)

  • 21. Binding of hepatitis B virus to its cellular receptor alters the expression profile of genes of bile acid metabolism.
    Oehler N; Volz T; Bhadra OD; Kah J; Allweiss L; Giersch K; Bierwolf J; Riecken K; Pollok JM; Lohse AW; Fehse B; Petersen J; Urban S; Lütgehetmann M; Heeren J; Dandri M
    Hepatology; 2014 Nov; 60(5):1483-93. PubMed ID: 24711282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microbially catalyzed conjugation of GABA and tyramine to bile acids.
    Mullowney MW; Fiebig A; Schnizlein MK; McMillin M; Rose AR; Koval J; Rubin D; Dalal S; Sogin ML; Chang EB; Sidebottom AM; Crosson S
    J Bacteriol; 2024 Jan; 206(1):e0042623. PubMed ID: 38174933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver disease.
    Lin MJ; Su TH; Chen CC; Wu WK; Hsu SJ; Tseng TC; Liao SH; Hong CM; Yang HC; Liu CJ; Wu MS; Kao JH
    Gut Pathog; 2023 May; 15(1):24. PubMed ID: 37218009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gut microbiota of hepatitis B virus-infected patients in the immune-tolerant and immune-active phases and their implications in metabolite changes.
    Li YN; Kang NL; Jiang JJ; Zhu YY; Liu YR; Zeng DW; Wang F
    World J Gastroenterol; 2022 Sep; 28(35):5188-5202. PubMed ID: 36188719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide.
    Yan H; Peng B; Liu Y; Xu G; He W; Ren B; Jing Z; Sui J; Li W
    J Virol; 2014 Mar; 88(6):3273-84. PubMed ID: 24390325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bile Acid Profiles Are Distinct among Patients with Different Etiologies of Chronic Liver Disease.
    Sang C; Wang X; Zhou K; Sun T; Bian H; Gao X; Wang Y; Zhang H; Jia W; Liu P; Xie G; Chen T
    J Proteome Res; 2021 May; 20(5):2340-2351. PubMed ID: 33754726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fecal microbiome and bile acid metabolome in adult short bowel syndrome.
    Boutte HJ; Chen J; Wylie TN; Wylie KM; Xie Y; Geisman M; Prabu A; Gazit V; Tarr PI; Levin MS; Warner BW; Davidson NO; Rubin DC
    Am J Physiol Gastrointest Liver Physiol; 2022 Jan; 322(1):G154-G168. PubMed ID: 34816756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preserved Gut Microbial Diversity Accompanies Upregulation of TGR5 and Hepatobiliary Transporters in Bile Acid-Treated Animals Receiving Parenteral Nutrition.
    Jain AK; Sharma A; Arora S; Blomenkamp K; Jun IC; Luong R; Westrich DJ; Mittal A; Buchanan PM; Guzman MA; Long J; Neuschwander-Tetri BA; Teckman J
    JPEN J Parenter Enteral Nutr; 2017 Feb; 41(2):198-207. PubMed ID: 27503935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bile acid is a significant host factor shaping the gut microbiome of diet-induced obese mice.
    Zheng X; Huang F; Zhao A; Lei S; Zhang Y; Xie G; Chen T; Qu C; Rajani C; Dong B; Li D; Jia W
    BMC Biol; 2017 Dec; 15(1):120. PubMed ID: 29241453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microbial and metabolic features associated with outcome of infliximab therapy in pediatric Crohn's disease.
    Wang Y; Gao X; Zhang X; Xiao F; Hu H; Li X; Dong F; Sun M; Xiao Y; Ge T; Li D; Yu G; Liu Z; Zhang T
    Gut Microbes; 2021; 13(1):1-18. PubMed ID: 33430702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bile acids associate with specific gut microbiota, low-level alcohol consumption and liver fibrosis in patients with non-alcoholic fatty liver disease.
    Adams LA; Wang Z; Liddle C; Melton PE; Ariff A; Chandraratna H; Tan J; Ching H; Coulter S; de Boer B; Christophersen CT; O'Sullivan TA; Morrison M; Jeffrey GP
    Liver Int; 2020 Jun; 40(6):1356-1365. PubMed ID: 32243703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of complement component 2 expression by hepatitis B virus contributes to the viral persistence in chronic hepatitis B patients.
    Ning G; Zhen LM; Xu WX; Li XJ; Wu LN; Liu Y; Xie C; Peng L
    J Viral Hepat; 2020 Oct; 27(10):1071-1081. PubMed ID: 32384193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Landscapes of gut microbiome and bile acid signatures and their interaction in HBV-associated acute-on-chronic liver failure.
    Bao Z; Wei R; Zheng X; Zhang T; Bi Y; Shen S; Zou P; Zhang J; Yan H; Li MD; Yang Z; Gao H
    Front Microbiol; 2023; 14():1185993. PubMed ID: 37275140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum interleukin-37 concentrations and HBeAg seroconversion in chronic HBV patients during telbivudine treatment.
    Li C; Ji H; Cai Y; Ayana DA; Lv P; Liu M; Jiang Y
    J Interferon Cytokine Res; 2013 Oct; 33(10):612-8. PubMed ID: 23697556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered oral microbiota in chronic hepatitis B patients with different tongue coatings.
    Zhao Y; Mao YF; Tang YS; Ni MZ; Liu QH; Wang Y; Feng Q; Peng JH; Hu YY
    World J Gastroenterol; 2018 Aug; 24(30):3448-3461. PubMed ID: 30122883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gut microbiota dysbiosis in patients with hepatitis B virus-related cirrhosis.
    Shu W; Shanjian C; Jinpiao L; Qishui O
    Ann Hepatol; 2022; 27(2):100676. PubMed ID: 35093600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colesevelam attenuates cholestatic liver and bile duct injury in
    Fuchs CD; Paumgartner G; Mlitz V; Kunczer V; Halilbasic E; Leditznig N; Wahlström A; Ståhlman M; Thüringer A; Kashofer K; Stojakovic T; Marschall HU; Trauner M
    Gut; 2018 Sep; 67(9):1683-1691. PubMed ID: 29636383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unconjugated and secondary bile acid profiles in response to higher-fat, lower-carbohydrate diet and associated with related gut microbiota: A 6-month randomized controlled-feeding trial.
    Wan Y; Yuan J; Li J; Li H; Zhang J; Tang J; Ni Y; Huang T; Wang F; Zhao F; Li D
    Clin Nutr; 2020 Feb; 39(2):395-404. PubMed ID: 30876827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gut microbial profile in biliary atresia: a case-control study.
    Wang J; Qian T; Jiang J; Yang Y; Shen Z; Huang Y; Chen G; Zheng S; Dong R
    J Gastroenterol Hepatol; 2020 Feb; 35(2):334-342. PubMed ID: 31271681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Profiling of serum bile acids in a healthy Chinese population using UPLC-MS/MS.
    Xie G; Wang Y; Wang X; Zhao A; Chen T; Ni Y; Wong L; Zhang H; Zhang J; Liu C; Liu P; Jia W
    J Proteome Res; 2015 Feb; 14(2):850-9. PubMed ID: 25581415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.